ROSSI EMANUELA

Ruolo:
Tecnica – amministrativa
Telefono:

Pubblicazioni

  • Cristoferi, L., D'Amato, D., Maino, C., Bernasconi, D., Dinelli, M., Malandrin, S., et al. (2026). Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial. BMJ OPEN, 16(1) [10.1136/bmjopen-2025-106630]. Dettaglio

  • Turati, M., Tosoni, D., Benedettini, E., Albanese, F., Alessandro, C., Rossi, E., et al. (2025). Hamstring–quadriceps strength ratio at different movement velocities in healthy young adults. SPORT SCIENCES FOR HEALTH, 21(4), 2795-2804 [10.1007/s11332-025-01483-x]. Dettaglio

  • Hertz, D., Tanay, M., Tofthagen, C., Rossi, E., Bernasconi, D., Sheffield, K., et al. (2025). Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy. SUPPORTIVE CARE IN CANCER, 33(2) [10.1007/s00520-025-09190-6]. Dettaglio

  • Velasco, R., Argyriou, A., Cornblath, D., Bruna, P., Alberti, P., Rossi, E., et al. (2024). Repurposing chemotherapy-induced peripheral neuropathy grading. EUROPEAN JOURNAL OF NEUROLOGY, 31(12 (December 2024)) [10.1111/ene.16457]. Dettaglio

  • Soria, A., Graziano, F., Ghilardi, G., Lapadula, G., Gasperina, D., Benatti, S., et al. (2024). Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort. HELIYON, 10(16) [10.1016/j.heliyon.2024.e36102]. Dettaglio